Just one month after the American Medical Association (AMA) classified obesity as a disease, a study published July 17 in JAMA adds weight to the argument that preventing or delaying the onset of obesity as a young adult offers health dividends later.

Zoll Medical is expanding its cardiovascular portfolio by acquiring assets from the maker of a cardiopulmonary life support system.

One-year mortality rates remained similar for patients with prosthetic valve endocarditis who received early surgery or medical therapy in an observational study that adjusted for biases. The study was published online July 15 in JAMA: Internal Medicine.

Abbott plans to buy IDEV Technologies for $310 million, a move that will expand Abbott’s portfolio of stents for treating peripheral artery disease.

Cardiac rehabilitation (CR) after CABG improved long-term survival in a community-based study, supporting American Heart Association and American College of Cardiology Foundation guidelines recommending CR for this group of patients.

Enhancing its product leadership team, Toshiba America Medical Systems, Inc. has named David Sloop director, X-ray Vascular Business Unit. Sloop will be responsible for implementing strategic marketing plans to drive growth and profitability of Toshiba’s X-ray Vascular product line.

A German court ruled July 12 that Medtronic infringed on a transcatheter heart valve patent owned by Edwards Lifesciences. Medtronic, which was ordered to recall its CoreValve and CoreValve Evolut systems in Germany, said that it planned to appeal the decision. 

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla™ Guide Extension Catheter and has launched the device in the U.S. and Europe.